Skip to main content
Premium Trial:

Request an Annual Quote

Taiwan s CGMH Expands Use of Bruker Daltonics Mass Spec Technology

NEW YORK, April 4 (GenomeWeb News) - The Chang-Gung Memorial Hospital has expanded its use of Bruker Daltonics mass-spectrometry instrumentation to include one of its operating clinics in Kaohsiung, the hospital said today.


CGMH, based in Taipei, implemented a Bruker ClinProt system for MALDI-TOF mass spectrometry-based clinical proteomics and biomarker analysis at its facility in Linkou last year. Now, it will establish a similar ClinProt set up in Kaohsiung, CGMH said.


Additionally, the existing ClinProt platform in Linkou will be expanded by additional sample preparation and mass spectrometry technologies to analyze and identify potential protein biomarkers, CGMH said.


Specific terms of CGMH's arrangement with Bruker were not disclosed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.